The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 15%.
Abrdn Healthcare Investors HQH
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc.
read at $22.34
Abrdn Healthcare Investors holds its Accumulation at $22.34.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 5 days |
| Price | $22.34 |
| Valuation | 5.00 trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.73 |
The business, in plain words · what the numbers mean
| Trailing P/E | 5.0x very cheap relative to earnings |
| Revenue growth | -42.1% revenue is shrinking |
| Profit margin | 4,561.3% highly profitable on every dollar of sales |
| Return on equity | 24.2% an exceptional return on shareholder capital |
| Current ratio | 1.03 adequate liquidity, worth monitoring |
| Beta | 0.73 steadier than the market |
| Market cap | $1.3B |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in HQH's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
HQH trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 15%.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $19.45 | -3.5% | $0.61 | $996 | -0.4% |
| 2 months | $18.38 | +2.1% | $0.61 | $1,054 | +5.4% |
| 3 months | $17.72 | +5.9% | $0.61 | $1,093 | +9.3% |
| 6 months | $17.85 | +5.1% | $1.24 | $1,120 | +12.0% |
| 1 year | $14.00 | +34.0% | $2.32 | $1,506 | +50.6% |
| 2 years | $13.13 | +42.9% | $4.64 | $1,782 | +78.2% |
| 3 years | $11.81 | +58.8% | $6.49 | $2,138 | +113.8% |
| 5 years | $14.82 | +26.6% | $10.05 | $1,945 | +94.5% |
Historical returns from market close data. Past performance does not guarantee future results.